BACKGROUND--Patients admitted with acute exacerbation of chronic obstructive pulmonary
disease (COPD) are often prescribed ipratropium bromide in combination with a beta 2 …

Bronchodilator efficacy of salbutamol (200 μg), salmeterol (50 μg) and ipratropium bromide
(40 μg) aerosols las been compared in 16 patients with stable chronic obstructive pulmonary …

BACKGROUND--The acute response to bronchodilators in patients with chronic obstructive
pulmonary disease (COPD) is modest; it has, however, been suggested that these patients …

Combination bronchodilator therapy for chronic obstructive pulmonary disease (COPD) is
available widely throughout the world except in North America. Previous studies have …

This study evaluates the effect of three different bronchodilators (beta 2-adrenergic,
anticholinergic and methylxanthine) alone and in randomized sequence, during an …

The bronchodilator efficacy, safety, and persistence of effect of the anticholinergic agent
ipratropium bromide and the β-adrenergic agonist albuterol, both given by nebulization …

Several studies have suggested that anticholinergics are at least equal to or may be
superior to beta agonists in the treatment of stable COPD. However, since most previous …

BACKGROUND--Inhaled anticholinergics and beta agonists are widely used in the
treatment of patients with chronic obstructive pulmonary disease (COPD). However, dosage …

Single dose studies have assessed the utility of ipratropium bromide alone or with beta
agonists in the short-and long-term management of chronic obstructive lung disease and …

The efficacy and safety of salmeterol alone was compared with the combination of
salmeterol plus ipratropium and with placebo during long-term treatment in patients with …